Stay updated on Enhancing Antitumor Immunity with Electroporation Clinical Trial
Sign up to get notified when there's something new on the Enhancing Antitumor Immunity with Electroporation Clinical Trial page.

Latest updates to the Enhancing Antitumor Immunity with Electroporation Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedAdded content mentioning squamous cell carcinoma of the head and neck and a Genetic and Rare Diseases Information Center resource.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision: v3.5.0 replaces v3.4.3 on the page. This appears to be a backend/site version update with no changes to the study content.SummaryDifference0.0%

- Check31 days agoChange DetectedAdded Revision: v3.4.3; Deleted Revision: v3.4.2.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision: v3.4.2 is now shown; the earlier government funding status notice (v3.4.1) has been removed. These updates are administrative and do not modify study data, eligibility criteria, or outcomes.SummaryDifference0.4%

- Check67 days agoChange DetectedAdded a site-wide notice about government funding status and the NIH Clinical Center's open status, and updated the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check74 days agoChange DetectedA glossary toggle was added, QC-related labels were updated (e.g., 'Last Update Submitted that Met QC Criteria') and 'No FEAR Act Data' was added; the revision tag changed from v3.3.4 to v3.4.0.SummaryDifference0.2%

Stay in the know with updates to Enhancing Antitumor Immunity with Electroporation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enhancing Antitumor Immunity with Electroporation Clinical Trial page.